[
  {
    "ts": null,
    "headline": "Alcon Stock Sees RS Rating Climb To 74",
    "summary": "A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?",
    "url": "https://finnhub.io/api/news?id=72bffbbe99bf271893089579fa21d93cdba1c44087343967adec544940dd5978",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742929800,
      "headline": "Alcon Stock Sees RS Rating Climb To 74",
      "id": 133462121,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?",
      "url": "https://finnhub.io/api/news?id=72bffbbe99bf271893089579fa21d93cdba1c44087343967adec544940dd5978"
    }
  },
  {
    "ts": null,
    "headline": "Medical Products Leader Tops These Early-Bird Buy Points",
    "summary": "Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry.",
    "url": "https://finnhub.io/api/news?id=770c10a92f9c75b62343a4cb6ac7181f30f61a6f11906eafbdce327aba55d866",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742918945,
      "headline": "Medical Products Leader Tops These Early-Bird Buy Points",
      "id": 133444932,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry.",
      "url": "https://finnhub.io/api/news?id=770c10a92f9c75b62343a4cb6ac7181f30f61a6f11906eafbdce327aba55d866"
    }
  },
  {
    "ts": null,
    "headline": "ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System",
    "summary": "Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.",
    "url": "https://finnhub.io/api/news?id=37a966965dcf3df754d3f0416bfab40fd1547c87e9cb38224506f2ef7c26a87d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742908560,
      "headline": "ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System",
      "id": 133444889,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.",
      "url": "https://finnhub.io/api/news?id=37a966965dcf3df754d3f0416bfab40fd1547c87e9cb38224506f2ef7c26a87d"
    }
  },
  {
    "ts": null,
    "headline": "Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval",
    "summary": "ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing visual outcomes with cutting-edge innovation.",
    "url": "https://finnhub.io/api/news?id=4b7745d1f9286c7505e9242f29e19260908d9c4f7176f53bd80b94b6bb38286f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742906640,
      "headline": "Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval",
      "id": 133375681,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing visual outcomes with cutting-edge innovation.",
      "url": "https://finnhub.io/api/news?id=4b7745d1f9286c7505e9242f29e19260908d9c4f7176f53bd80b94b6bb38286f"
    }
  },
  {
    "ts": null,
    "headline": "ALC Stock Rises Following the Merger Agreement With LENSAR",
    "summary": "Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system.",
    "url": "https://finnhub.io/api/news?id=db552902a9c57060617b4924d658eb9b4539660a03489c4e711d5d4076bd8268",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742906100,
      "headline": "ALC Stock Rises Following the Merger Agreement With LENSAR",
      "id": 133375682,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system.",
      "url": "https://finnhub.io/api/news?id=db552902a9c57060617b4924d658eb9b4539660a03489c4e711d5d4076bd8268"
    }
  },
  {
    "ts": null,
    "headline": "Should You Consider Retaining PBH Stock in Your Portfolio Now?",
    "summary": "Investors remain optimistic about Prestige Consumer due to its strong focus on brand building and strategic acquisition.",
    "url": "https://finnhub.io/api/news?id=facbdcc792e0929eaa4b6f31760b8185beb514ec04b2b9475bd9d3eb615e3fa9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742904660,
      "headline": "Should You Consider Retaining PBH Stock in Your Portfolio Now?",
      "id": 133375683,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investors remain optimistic about Prestige Consumer due to its strong focus on brand building and strategic acquisition.",
      "url": "https://finnhub.io/api/news?id=facbdcc792e0929eaa4b6f31760b8185beb514ec04b2b9475bd9d3eb615e3fa9"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic",
    "summary": "Boston Scientific, Abbott and Medtronic are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=d4cd735ddb2ba1122894600df60e46088cb79fc5d4e2375a2e4adedfe14b6c0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742886540,
      "headline": "The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic",
      "id": 133367629,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific, Abbott and Medtronic are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=d4cd735ddb2ba1122894600df60e46088cb79fc5d4e2375a2e4adedfe14b6c0b"
    }
  }
]